Latest news
Invitation to Q1 2020 results presentation
Oslo, Norway, 28 April 2020 – PCI Biotech’s Q1 2020 interim report will be released on 6 May, 2020 at 07.00 CEST. The interim report and presentation will be made available on www.newsweb.no and on the company’s webpage, www.pcibiotech.com. A results presentation (in English) will be held through a webcast at 08.30 CEST the […]
PCI Biotech Holding ASA publishes the Annual Report 2019
Oslo, Norway, April 22, 2020 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2019 and the report is attached. The Annual Report 2019 is also available on the company’s website www.pcibiotech.com. For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Per Walday, CEO, pw@pcibiotech.no, […]
PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
Oslo, Norway, 31 March 2020 – PCI Biotech announces the appointment of Dr Amir Snapir, MD, PhD as Chief Medical Officer (CMO). Dr Snapir will also serve as a member of PCI Biotech’s executive management team. He will lead the execution of all clinical development programmes, and be a key contributor to the identification and […]